| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 172 |
| 1 | RUXOLITINIB | 95 |
| 2 | DEFERASIROX | 91 |
| 3 | CYCLOPHOSPHAMIDE | 90 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 90 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 90 |
| 6 | PREDNISONE | 85 |
| 7 | ASPIRIN | 58 |
| 8 | ASPIRIN 325 MG | 58 |
| 9 | ASPIRIN 81 MG | 58 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM IODIDE I 123 | 15 | 0.0160 |
| 1 | SODIUM IODIDE I 131 | 15 | 0.0156 |
| 2 | AXATILIMAB-CSFR | 1 | 0.0061 |
| 3 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 2 | 0.0050 |
| 4 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 5 | AMMONIUM CHLORIDE | 1 | 0.0040 |
| 6 | DEFERASIROX | 91 | 0.0034 |
| 7 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 1 | 0.0034 |
| 8 | MOMELOTINIB | 5 | 0.0034 |
| 9 | PSYLLIUM HUSK | 4 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 177 |
| 1 | Corticosteroid [EPC] | 168 |
| 2 | Kinase Inhibitor [EPC] | 130 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 126 |
| 4 | Alkylating Drug [EPC] | 114 |
| 5 | Janus Kinase Inhibitor [EPC] | 99 |
| 6 | Iron Chelator [EPC] | 91 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 84 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 59 |
| 9 | Azole Antifungal [EPC] | 55 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Iron Chelator [EPC] | 91 | 0.0031 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 26 | 0.0012 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 15 | 0.0010 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 7 | CD33-directed Immunoconjugate [EPC] | 3 | 0.0008 |
| 8 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 9 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |